This not only highlights that the catalytic activity of DCLK1 may regulate additional tumor-promoting cellular processes, but also argues for a need to develop (isoform) selective DCLK1 inhibitors to dissect the contribution of DCLK1 kinase activity to tumorigenesis [54]. This evidence concerns the gene DCLK1 and neoplasm.